87 related articles for article (PubMed ID: 1374741)
1. Protective effect of SPR-901 (RBS) on the decrease of peripheral leukocyte number in 5-fluorouracil-treated mice.
Miyazaki H; Yoshikai Y; Tanaka M; Takeda Y; Takeo S; Nomoto K
Int J Immunopharmacol; 1992 Jan; 14(1):11-7. PubMed ID: 1374741
[TBL] [Abstract][Full Text] [Related]
2. Hematologic effects of interleukin-1 beta, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor in tumor-bearing mice treated with fluorouracil.
Moore MA; Stolfi RL; Martin DS
J Natl Cancer Inst; 1990 Jun; 82(12):1031-7. PubMed ID: 1693405
[TBL] [Abstract][Full Text] [Related]
3. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
[TBL] [Abstract][Full Text] [Related]
4. Interactions among colony-stimulating factors, IL-1 beta, IL-6, and kit-ligand in the regulation of primitive murine hematopoietic cells.
Muench MO; Schneider JG; Moore MA
Exp Hematol; 1992 Mar; 20(3):339-49. PubMed ID: 1373685
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of host defense by Y-25510, (+-)-3-[4-(2-dimethylamino-1-methylethoxy)phenyl]-1H-pyrazolo[3,4 -b] pyridine-1-acetic acid, a novel synthetic compound. A comparison with recombinant human granulocyte colony-stimulating factor in 5-fluorouracil-treated mice.
Hisadome M; Fukuda T; Terasawa M; Oe T; Takahata H; Goto K; Tsuru S; Nomoto K
Int J Immunopharmacol; 1992 Oct; 14(7):1195-201. PubMed ID: 1280628
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory effects of moxifloxacin in comparison to ciprofloxacin and G-CSF in a murine model of cyclophosphamide-induced leukopenia.
Shalit I; Kletter Y; Halperin D; Waldman D; Vasserman E; Nagler A; Fabian I
Eur J Haematol; 2001 May; 66(5):287-96. PubMed ID: 11422407
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of a recombinant and a mutein type of granulocyte colony stimulating factor on the growth of Meth-A fibrosarcoma with 5-fluorouracil chemotherapy.
Nio Y; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Kawabata K; Masai Y; Fukumoto M; Tobe T
Biotherapy; 1992; 4(2):81-6. PubMed ID: 1377928
[TBL] [Abstract][Full Text] [Related]
8. Effect of rosiglitazone, an insulin sensitizer, on myelotoxicity caused by repeated doses of 5-fluorouracil.
Djazayeri K; Szilvássy Z; Benko K; Rózsa B; Szabó B; Szentmiklósi AJ; Benko I
Pharmacol Res; 2006 Feb; 53(2):156-61. PubMed ID: 16338143
[TBL] [Abstract][Full Text] [Related]
9. Secondary cytokines interact in sequence with interleukin-1alpha (IL-1alpha) with or without macrophage colony-stimulating factor (M-CSF) to further accelerate granulopoietic recovery in myelosuppressed animals.
Kovacs CJ; Evans MJ; Daly BM; Thomas-Patterson D; Johnke RM; Powell DS
J Interferon Cytokine Res; 1997 Aug; 17(8):453-60. PubMed ID: 9282825
[TBL] [Abstract][Full Text] [Related]
10. Possible role of stem cell factor as a serum factor: monoclonal anti-c-kit antibody abrogates interleukin-6-dependent colony growth in serum-containing culture.
Shiohara M; Koike K; Kubo T; Amano Y; Takagi M; Muraoka K; Nakao J; Nakahata T; Komiyama A
Exp Hematol; 1993 Jul; 21(7):907-12. PubMed ID: 7686504
[TBL] [Abstract][Full Text] [Related]
11. Improved recovery of myelosuppression following chemotherapy in mice by combined administration of PSK and various cytokines.
Kohgo Y; Hirayama Y; Sakamaki S; Matsunaga T; Ohi S; Kuga T; Kato J; Niitsu Y
Acta Haematol; 1994; 92(3):130-5. PubMed ID: 7532894
[TBL] [Abstract][Full Text] [Related]
12. Indomethacin augments granulocyte-macrophage colony-stimulating factor-induced hematopoiesis following 5-FU treatment.
O'Reilly M; Gamelli RL
Exp Hematol; 1990 Oct; 18(9):974-8. PubMed ID: 2204540
[TBL] [Abstract][Full Text] [Related]
13. Effect of in vivo administration of IL-3 and IL-6, alone and in combination with G-CSF, GM-CSF or IL-1, on haematopoiesis, graft-versus-host disease and survival after murine haematopoietic stem cell transplantation.
Atkinson K; Vos B; Kang-Er Z; Guiffre A; Seymour R; Gillis S
Cytokines Mol Ther; 1995 Mar; 1(1):47-55. PubMed ID: 9384663
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of ren-shen-yang-rong-tang (Ninjin-youei-to) in mice with drug-induced leukopenia against Pseudomonas aeruginosa infection.
Miura S; Takimoto H; Yoshikai Y; Kumazawa Y; Yamada A; Nomoto K
Int J Immunopharmacol; 1992 Oct; 14(7):1249-57. PubMed ID: 1280629
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
McCrady CW; Li F; Pettit GR; Grant S
Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of granulopoiesis by transforming growth factor beta: synergy with granulocyte/macrophage-colony-stimulating factor.
Keller JR; Jacobsen SE; Sill KT; Ellingsworth LR; Ruscetti FW
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7190-4. PubMed ID: 1831268
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 1-induced sequential myelorestoration: dynamic relation between granulopoiesis and progenitor cell recovery in myelosuppressed mice.
Ido M; Harada M; Furuichi H; Matsuoka N; Nakano K; Sohmura Y
Exp Hematol; 1992 Feb; 20(2):161-6. PubMed ID: 1371964
[TBL] [Abstract][Full Text] [Related]
18. The effect of granulocyte macrophage-colony stimulating factor on bacterial translocation after administration of 5-fluorouracil in rats.
Kucuk C; Ozkan M; Akgun H; Muhtaroglu S; Sozuer E
J Surg Res; 2005 Sep; 128(1):15-20. PubMed ID: 15975592
[TBL] [Abstract][Full Text] [Related]
19. Effects of interleukin 3, interleukin 6, and granulocyte colony-stimulating factor on sorted murine splenic progenitor cells.
Okada S; Suda T; Suda J; Tokuyama N; Nagayoshi K; Miura Y; Nakauchi H
Exp Hematol; 1991 Jan; 19(1):42-6. PubMed ID: 1703493
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte-colony-stimulating factor enhances the circulating hematopoietic progenitors in lung cancer patients treated with cisplatin-containing regimens.
Mukai J; Shimizu E; Ogura T
Jpn J Cancer Res; 1992 Jul; 83(7):746-53. PubMed ID: 1381342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
